FDAnews
www.fdanews.com/articles/187032-tela-bio-earns-ce-mark-for-reinforced-bioscaffolds

TELA Bio Earns CE Mark for Reinforced Bioscaffolds

May 31, 2018

Surgical reconstruction company TELA Bio received a CE Mark for its OviTex reinforced bioscaffolds for use in soft tissue repair and announced plans for a European launch.

The company first commercialized the product in the U.S. for ventral hernia repairs and abdominal wall reconstruction procedures.

The reinforced bioscaffolds are surgical implants that blend biologic and synthetic materials and allow movement of fluid and cells as well as functional tissue remodeling.

View today's stories